Want to join the conversation?
$VRX said it agreed to divest all North American commercialization rights to Ruconest (recombinant human C1 esterase inhibitor) to Pharming Group. Pharming will pay $VRX aggregate consideration of up to $125MM, including upfront fee of $60MM payable upon closing and certain sales-based milestone payments of up to $65MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?